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1. Introduction 
Surgical therapy for aortic arch disease involves partial or complete replacement of the 
aortic arch with reimplantation of the great vessels while the cerebral blood flow is 
temporarily altered. Patients undergoing this mandatory period of circulatory arrest during 
arch replacement are at an increased risk for adverse neurologic outcomes, and strategies for 
cerebral protection must be implemented to achieve successful results. The optimal strategy 
for management of the circulation during aortic arch surgery remains controversial. Arch 
reconstruction has historically been associated with significant morbidity and mortality due 
to global ischemic end-organ damage occurring during the circulatory arrest period.  As 
surgical techniques have evolved, survival has improved; however, neurologic dysfunction 
due to cerebral ischemia remains a significant concern.  
Profound hypothermia was the initial method of cerebral protection utilized during the 
period of circulatory arrest. The first successful series of arch reconstructions using deep 
hypothermic circulatory arrest (DHCA) with body temperatures of 18°C was reported in 
1975 (1). Further efforts to improve cerebral protection during arch reconstruction have led 
to the development of antegrade cerebral perfusion (ACP) and retrograde cerebral perfusion 
(RCP). Both techniques provide continuous blood flow to the brain and are used in 
conjunction with hypothermic circulatory arrest (HCA). The optimal method of cerebral 
perfusion (antegrade vs. retrograde) is a controversial topic and has yet to be determined. In 
the this chapter, the indications for aortic arch surgery will be delineated, and the various 
methods of cerebral protection strategies and their results will be reviewed. 
2. Pathology/indications for aortic arch surgery 
The most common indication for arch replacement is the presence of aneurysmal disease. 
The most common type of arch aneurysm is a degenerative aneurysm. The media of the 
aortic wall in degenerative aneurysms develops cellular necrosis which results in a loss of 
smooth muscle cells that are replaced by cystic spaces filled with mucoid material. Dr. 
Cooley coined the phrase cystic medial necrosis to describe this characteristic histologic 
pattern found in degenerative aneurysms (2). These aneurysms also have a significant 
reduction in elastin content due to a poorly understood increase in elastin fragmentation.  
The second most common cause of arch aneurysms is atherosclerosis. The development of 
invasive atheromas is thought to destroy the elastin fibers and smooth muscle cells of the 
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aortic media resulting in aneurysm formation.(3). Inherited genetic connective tissue 
disorders such as Marfan syndrome, Ehlers-Danlos and Loeys-Dietz syndrome are less 
common causes of arch aneurysms. Familial arch aneurysms are a subtype of heritable 
aneurysms which do not express a recognizable phenotype of a known connective tissue 
disorder, and do not have a specific gene or product which has been identified (3). Bicuspid 
aortic valve (BAV) disease is a congenital anomaly occurring in 0.9-2% of the population 
which is associated with an intrinsic aortopathy that leads to the development of proximal 
arch aneurysms. BAV aneurysms are thought to be due to an abnormal extracellular matrix 
of the aortic wall. Infection is a rare cause of (mycotic) arch aneurysms and requires 
replacement with aortic homograft. 
The presence or absence of symptoms is the most important factor in the management of 
patients with arch aneurysms. Most patients with arch aneurysms are asymptomatic, and 
the aneurysm is discovered incidentally on radiographic imaging obtained for another 
purpose. Patients with symptomatic arch aneurysms typically experience chest or back pain. 
However, symptoms can also include compression or stretching of surrounding anatomic 
structures. Tracheal compression can cause stridor, esophageal compression may result in 
dysphagia, superior vena cava compression can cause plethora, and aneurysmal stretching 
of the recurrent laryngeal nerve produces hoarseness. The sudden onset of pain is 
considered an ominous warning sign of imminent rupture or dissection, and urgent surgery 
is indicated for all patients with symptomatic arch aneurysms (4).  Operative therapy for 
asymptomatic arch aneurysms is performed for prophylactic replacement of the aorta in 
order to prevent rupture or dissection, and thereby improve patient survival. Total aortic 
arch replacement for an isolated arch aneurysm should be performed at sizes ≥ 5.5cm. Rapid 
expansion of the aneurysm at a rate ≥0.5cm/year is another indication for surgery. 
Concomitant proximal (hemi-) arch replacement is recommended at the time of ascending 
aortic replacement if the proximal arch is enlarged (4).  
The other common indication for surgical intervention on the aortic arch is acute Type A 
aortic dissection. Surgical treatment of acute Type A aortic dissection requires resection of 
the primary tear, restoration of aortic valve competency, aortic replacement, and obliteration 
of the false lumen at the proximal and distal anastomoses. The distal extent of aortic 
replacement depends upon whether the arch is involved in the dissection. Arch involvement 
requires hemi-arch or total arch replacement under circulatory arrest using an open distal 
anastomosis. Total arch replacement in the setting of acute Type A aortic dissection is 
recommended when the arch is aneurysmal or there is extensive destruction or leakage (4). 
Nevertheless, it should be emphasized that total arch replacement significantly increases the 
risk of stroke and death during repair of an acute Type A dissection and should only be 
performed by experienced surgeons. 
3. Cerebral protection strategies 
3.1 Deep hypothermic circulatory arrest 
In 1952, John Lewis used systemic hypothermia at 28°C and inflow occlusion to perform the 
first successful atrial septal defect repair in a 5 year old girl (5). Systemic hypothermia was 
gradually phased out with the introduction of the cardiopulmonary bypass machine, but 
was rediscovered and used by separate investigators in isolated reports of aortic arch 
replacement in the 1960’s (6,7). Dr. Griepp reported the first successful series of total arch 
replacements in adults in 1975, using deep hypothermic circulatory arrest) at 18°C for 
cerebral protection (1). 
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The technique of DHCA for aortic arch replacement involves placing the patient on 
cardiopulmonary bypass and initiating systemic hypothermia to a core temperature of 18°C. 
Once this core temperature has been achieved, cardiopulmonary bypass is interrupted and 
the systemic circulation is arrested.  The aortic arch is resected and reconstructed, deairing 
maneuvers are performed, and cardiopulmonary bypass is resumed. The exact mechanism 
of cerebral protection afforded by deep hypothermia is not completely understood, but its 
main beneficial effect is the suppression of cerebral metabolism. This is important because it 
enables an extension of the period of cerebral ischemic tolerance required for arch 
replacement.  
Systemic hypothermia at 20°C has been shown to reduce the cerebral metabolic rate by 76% 
(8) (Table 1). It has also been postulated that there is an uncoupling of cerebral blood flow 
and cerebral metabolism at approximately 22˚C, likely due to a loss of autoregulation in the 
cerebral vasculature. The ratio of cerebral blood flow to cerebral metabolism increases from 
20:1 at normothermia, to 75:1 with deep hypothermia (9). Once the period of DHCA has 
been completed and cerebral reperfusion has been initiated, severe cerebral vasoconstriction 
occurs. There is also an accumulated cerebral oxygen debt from the ischemic period which 
must be “paid back”, and therefore, normal levels of cerebral metabolism are maintained by 
increased oxygen extraction (10, 11, 12). During the period following DHCA, the brain is at 
high risk for both ongoing ischemic injury due to low cerebral blood flow, and reperfusion 
injury.  There has also been experimental data to suggest that following DHCA, there is an 
increase in intracranial pressure due to cerebral edema which negatively impacts 
neurophysiologic recovery (13). 
 
 
Table 1. From McCullough JN, Zhang N, Reich DL et al. Cerebral metabolic suppresion 
during hypothermic circulatory arrest in humans. Ann Thorac Surg 1999; 67:1895-1921. 
Cerebral injury following procedures requiring circulatory arrest is manifested clinically as 
post-operative transient or permanent neurologic injury. Permanent neurologic dysfunction 
(PND) appears as a focal neurologic deficit or stroke, which is thought to be the result of 
embolic phenomena. The incidence of PND following arch reconstruction has been shown to 
be directly related to the site of arterial cannulation (14). Transient neurologic deficit (TND) 
is defined as postoperative confusion, delirium, obtundation, or transient focal deficits 
(resolution within 24 hours) with negative brain computed tomography or magnetic 
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resonance imaging scans. TND is a reversible, diffuse, subtle injury which is an indicator of 
global cerebral injury due to inadequate cerebral protection. TND following arch 
reconstruction using DHCA alone has been shown to occur in approximately 25% of all 
cases, and a linear relationship has been demonstrated between the incidence of TND and 
the duration of DHCA (15, 16, 17).   
In order to limit adverse neurologic outcomes, many investigations have focused upon 
determining a “safe” duration of DHCA. Based upon direct measurements of cerebral 
metabolism in adults, the safe period of DHCA has been estimated to be 30 minutes at 15°C, 
and 40 minutes at 10°C. Cellular anoxia occurs when these time periods are exceeded. (8). In a 
series of 656 patients undergoing arch surgery with DHCA alone, Svensson and colleagues 
reported a 10% mortality rate, and a 7% incidence of transient or permanent stroke. In a 
multivariate analysis, these authors demonstrated an increased risk of stroke following a 
period of DHCA > 40 minutes, and an increased mortality rate following a DHCA period >65 
minutes (18). Griepp’s group reported a 22% incidence of TND in 443 patients undergoing 
hemi-arch replacement with DHCA alone. In a multivariate analysis, these authors showed a 
DHCA time >30 minutes was an independent risk factor for TND (19). Using 
neuropsychologic tests, these investigators also demonstrated in a separate study that a DHCA 
duration > 25 minutes is a risk factor long-term deficits in neurocognitive function (20). 
DHCA was the first successful cerebral protection strategy used in aortic arch surgery. Over 
the past three decades, aortic surgeons have improved their techniques for arch replacement 
and novel strategies for circulation management and cerebral protection have evolved. 
However, for short circulatory arrest times ≤ 30 minutes, there are still many surgeons who 
achieve excellent outcomes with DHCA alone as their sole method of cerebral protection 
during arch reconstruction.  For more complex, extended arch reconstructions that require 
circulatory arrest times > 30 minutes, there is a consensus that DHCA alone is an inadequate 
cerebral protection strategy. In the current era, most experts in the field of aortic surgery use 
either antegrade or retrograde cerebral perfusion as an adjunctive method of cerebral 
protection in addtion to deep or moderate hypothermic circulatory arrest. (21).  
3.2 Retrograde Cerebral Perfusion 
Retrograde cerebral perfusion (RCP) was first described by Mills and Ochner as a method of 
treating a massive air embolus during cardiopulmonary bypass (22). RCP is employed by 
cannulating and snaring the superior vena cava, and infusing blood up the superior vena 
cava to perfuse the brain in a retrograde direction during the period of circulatory arrest. 
Flow rates are adjusted to achieve an SVC pressure of 20-25mm Hg. It is well recognized 
that RCP is a highly effective method of flushing embolic material from the cerebral 
circulation, and it maintains cerebral hypothermia by continuously bathing the brain in cold 
blood. There is a theoretical benefit that RCP can provide sufficient cerebral blood flow to 
support cerebral metabolism and remove toxic metabolites and waste products (9).  
Although there was initial enthusiasm for RCP’s ability to support cerebral metabolism, this 
hypothesis has subsequently been disproved. Multiple animal studies in different species 
have demonstrated minimal or no cerebral blood flow with the use of RCP (23, 24, 25). 
Although cerebral perfusion can be improved with higher retrograde perfusion pressures 
and occlusion of the inferior vena cava, there is a concomitant increase in cerebral edema 
with histologic evidence of cerebral injury (26). 
Many groups adopted the use of RCP in conjunction with DHCA in the 1990’s as their 
routine strategy for circulatory management during arch reconstruction with excellent 
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outcomes. Bavaria and colleagues demonstrated a significant improvement over previous 
reported series of Type A aortic dissection repairs using DHCA and RCP. In their series of 
104 patients, these investigators reported a 9% mortality rate and 5% stroke rate with a mean 
duration of DHCA+RCP of 42 minutes in 104 consecutive patients undergoing emergent 
repair of Type A aortic dissection (27). In a series of 479 patients undergoing arch surgery 
with DHCA for aneurysmal disease or dissection, Coselli compared the results using DHCA 
alone vs. DHCA+RCP. The subgroup who received DHCA+RCP had significantly reduced 
mortality (DHCA+RCP 3.4% vs. DHCA 14.8%, p<0.001) and stroke rates (DHCA+RCP 2.4% 
vs. DCHA 6.5%, p<0.05) (28).  
Estrera and colleagues also reported excellent results with the use of DHCA+RCP in both 
elective and emergent arch repairs. These investigators reported a mortality rate of 10.4% 
and a 2.8% stroke rate in a series of 1107 patients in which 907 (82%) patients received 
DHCA+RCP. However, the incidence of TND was 15.5% with relatively short mean RCP 
times of 26 minutes (29). Although this is lower than the 25% incidence of TND associated 
with arch reconstruction using DHCA alone (17), it is still a significant incidence of 
inadequate cerebral protection. Other groups have also reported a significant incidence of 
TND with the use of DHCA+RCP (30, 31, 32). The high incidence of TND and the recent 
popularity of antegrade cerebral perfusion has led to decreased utilization of RCP by most 
aortic surgeons (21). Nevertheless, RCP remains an important adjunctive cerebral protection 
strategy to DHCA is still used by many high volume aortic centers with excellent outcomes 
(33, 34). It is a highly effective anti-embolic technique which is especially useful for arch 
reconstruction in patients with carrying a heavy atherosclerotic burden. 
3.3 Antegrade Cerebral Perfusion 
Debakey and Cooley were the first to successfully describe the use of antegrade cerebral 
perfusion (ACP) in the surgical repair of an arch aneurysm (35). In their initial report, 
cannulas were placed into the right femoral artery and both carotid arteries, and a separate 
pump from the main cardiopulmonary bypass machine was used to perfuse normothermic 
blood into the carotid arteries. Despite its initial success, this method was considered 
complex and cumbersome, and was subsequently abandoned in favor of DHCA + RCP. The 
use of ACP began to reappear in reports of arch reconstructions in the late 1980’s. Bachet 
reported a 2.1% PND rate and a 4.3% TND rate with the use of ACP with “cold 
cerebroplegia” via bilateral carotid cannulation in a series of 54 patients (36). A year later, 
Kazui published excellent neurologic outcomes in a series of arch reconstructions by 
introducing catheters into the innominate and left common carotid arteries and providing 
ACP at a rate of 10mL/Kg/min during the period of DHCA. This perfusion rate was 
considered 50% of physiologic levels based upon experimental data, and has subsequently 
become the standard perfusion rate of ACP by most groups using this technique (37). 
During the 1990’s most centers performing a significant volume of aortic arch surgery began 
using either ACP or RCP as an adjunctive form of cerebral protection in addition to DHCA.  
It should be recognized that the utilization of ACP changes the paradigm of circulatory 
arrest. Circulatory arrest, as originally described, refers to the total arrest of the circulation 
and the absence of perfusion to all organs (except the heart via cardioplegia). The addition 
of ACP changes this concept from total body circulatory arrest to lower body circulatory 
arrest, as the brain, arms and the spinal cord (via collateral circulation) are being perfused. 
Therefore the legs and the abdominal visceral are the only truly ischemic organs during the 
circulatory arrest period with the use of ACP. 
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Different methods and nomenclature are used in the literature to describe ACP techniques. 
It is most commonly referred to as selective antegrade cerebral perfusion (SACP), because 
many surgeons introduce individual cathethers or cannulae into the orifices of the 
innominate and left common carotid arteries, thus selecting out the individual great vessels 
for cerebral perfusion. This is also referred to as bilateral selective antegrade cerebral 
perfusion (bSACP). Another modality is unilateral SACP (uSACP), which can refer to two 
different sites of cannulation. One method is to directly cannulate or sew a graft on to the 
base of the innominate artery to provide antegrade cerebral perfusion up the right common 
carotid artery. A different technique is to directly cannulate or sew a graft on to the right 
axillary artery. At the time of circulatory arrest, a clamp is placed across the base of the 
innominate artery, and blood is forced up the right common carotid. Both methods are 
considered uSACP. 
The hypothesis of ACP is that antegrade cerebral blood flow is more physiologic than no 
blood flow (HCA) or retrograde blood flow (RCP), and should therefore provide superior 
cerebral protection. Data from experimental animal models of DHCA comparing ACP and 
RCP have confirmed this hypothesis. Hagl and colleagues showed in an acute porcine 
model that a strategy of DHCA+ACP compared to DHCA alone is associated with 
improved neurophysiologic recovery, lower intracranial pressure, less cerebral edema, and 
reduced tissue acidosis following the circulatory arrest period (38). In a porcine model of 
circulatory arrest and reperfusion, Filgueiras and colleagues showed that near normal 
cerebral metabolism was maintained with DHCA+ACP, based upon pH measurements and 
levels of cerebral metabolites. The pigs who underwent DHCA+RCP or DHCA alone 
demonstrated a significant drop in cerebral pH during the protocol (39). In a separate study 
using the same model, these same investigators demonstrated preserved cell structure upon 
histopathologic analysis with HCA+ACP compared to HCA+RCP (40) 
The Mount Sinai group under Dr. Griepp has performed extensive laboratory work on the 
topic of ACP. These investigators determined that hypothermic SACP at 10˚-15˚C provides 
better cerebral protection than SACP at 20-25˚C based upon post-op behavioral scores in a 
chronic porcine circulatory arrest model (41).  They also showed that a short period of HCA 
prior to SACP initiation does not impact the level of cerebral protection compared to 
continuous SACP. This is important clinically because many surgeons will use a short 
period of HCA alone prior to initiating SACP to keep the field clean while they are 
performing arch resection in order to reduce the risk of atheroembolization (42).  Ye and 
colleagues compared unilateral and bilateral SACP to determine whether there was any 
difference in cerebral perfusion and cerebral protection between the two techniques. Using 
magnetic resonance perfusion imaging, these investigators compared cerebral blood volume 
and regional cerebral perfusion patterns in pigs undergoing circulatory arrest with uSACP 
via the right axillary artery to a separate group undergoing bSACP via bilateral carotid 
artery cannulation. Both methods provided uniform blood distribution to both cerebral 
hemispheres and preserved normal morphology of the cerebral neurons (43). 
Clinical studies have also supported DHCA+ACP as a superior method of cerebral 
protection compared to DHCA+RCP or DHCA alone. Using transcranial Doppler 
measurements during DHCA, Tanoue and colleagues demonstrated superior middle 
cerebral artery blood flow in patients undergoing DHCA+ACP compared to those 
undergoing DHCA+RCP (44).  Neri and colleagues demonstrated that the cerebrovascular 
autoregulation function was preserved in the immediate postoperative period in patients 
undergoing DHCA+ACP.  However, the autoregulatory function was significantly impaired 
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in patients undergoing DHCA alone or DHCA+RCP. Based upon the higher incidence of 
TND in the DHCA and DHCA+RCP groups, this post-operative impairment in cerebral 
autoregulation was considered to be an expression of CNS injury (45).  
Hagl reviewed the neurologic outcomes from the Mount Sinai experience of 717 patients 
undergoing arch replacement with the three different methods of cerebral protection. The 
incidence of stroke (PND) and TND was 5.7% and 30%. Due to significant differences in the 
circulatory arrest times, they were unable to determine whether the method of cerebral 
protection impacted the stroke rate. However, by using a multivariate analysis, the use of 
DHCA+ACP significantly reduced the incidence of TND compared to DHCA+RCP or 
DHCA alone (31). In a randomized controlled trials comparing ACP vs RCP for total arch 
replacements performed under DHCA, Okita and colleagues showed no difference in stroke 
between patients undergoing ACP vs RCP, however ACP significantly reduced the 
incidence of TND (ACP 13.3% vs. RCP 33.3%, p=0.05) (46). These results were also 
replicated in series of 48 patients undergoing arch reconstruction during type A aortic 
dissection repair. In this series, Apostolakis and colleagues reported no difference in 
mortality or PND between patients undergoing DHCA+ACP vs DHCA+RCP. However, the 
incidence of TND was significantly higher in the DHCA+RCP group (DHCA+RCP 43.5% vs. 
DHCA+ACP 16%, p=0.04) (47).  
In the current era, ACP has become the preferred method of cerebral protection employed 
by most aortic surgeons at the time of arch reconstruction (21). The lessons learned from the 
majority of studies comparing the various methods of cerebral protection are: 1)an adjunct 
form of cerebral protection (ACP or RCP) is superior to DHCA alone and 2)the method of 
cerebral perfusion (ACP or RCP) has no impact upon the incidence of PND, however ACP 
significantly reduces the incidence of TND.  
3.4 Moderate hypothermia 
Since Griepp’s initial report of the successful use of DHCA for cerebral protection during 
arch replacement, profound systemic hypothermia at a core temperature of 18°C has been 
the standard point of hypothermia at which most surgeons will initiate circulatory arrest. As 
discussed above, deep hypothermia affords excellent cerebral protection by suppressing 
cerebral metabolism. Studies in the field of transplantaiton have also demonstrated that 
hypothermia acts in a similar fashion in the preservation of organs (e.g. lungs, liver, heart, 
kidneys)(48). However, profound systemic hypothermia has been shown to have adverse 
effects in multiple organ systems including endothelial dysfunction, neuronal apoptosis, 
coagulopathy and renal failure (49, 50, 51, 52). The time required to cool and rewarm the 
body to 18°C leads to prolonged cardiopulmonary bypass which is detrimental to multiple 
organ system. Furthermore, deep hypothermia has been shown to be a strong risk factor for 
bleeding requiring re-exploration following arch reconstruction (16). Furthermore, despite 
the cerebral metabolic suppressive effects of profound hypothermia, a linear relationship 
has been demonstrated between the incidence of TND and the duration of DHCA alone (53). 
In an attempt to avoid the morbidity associated with DHCA, reduce cardiopulmonary 
bypass times and improve neurologic outcomes there has been a strong initiative from 
many different high volume aortic centers to begin performing arch replacements under 
moderate hypothermia circulatory arrest with ACP. This technique still provides maximum 
cerebral protection because the brain is being perfused with antegrade “cold cerebroplegia” 
at temperatures ≤ 18°C for ACP. It is the abdominal viscera which are the organs placed at 
risk with the technique of MCHA+ACP. However there has yet to be a report of increased 
risk of mesenteric ischemia, liver or renal failure with the use of MHCA. 
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Bachet’s initial description of arch reconstructions using “cold cerebroplegia” at 6˚-12˚C in 
1991 was also remarkable for the fact that he performed all of his arch reconstructions under 
moderate hypothermic circulatory arrest at core temperatures between 25-28°C (36). Using 
this technique he reported excellent neurologic outcomes with an incidence of PND and 
TND of 2.1% and 4.3% respectively. Minatoya and colleagues evaluated outcomes of 229 
patients who received arch reconstruction with HCA+bSACP at three different 
temperatures: 20˚C (n=81), 25˚C (n=81), and 28˚C (n=67). 81% of all patients received total 
arch replacement. There were no significant differences between the three groups with 
regards to the incidence of mortality, PND or TND (54). The use of MHCA+ACP for arch 
reconstruction has also been reported by several groups in the setting of acute Type A aortic 
dissection with results equivalent to those achieved with DHCA (55, 56, 57). 
At Emory, MHCA+uSACP is our preferred method of cerebral protection. All circulatory 
arrest cases are performed by cannulating an 8mm Dacron graft sewn to the right axillary 
artery. This is based upon a strong belief that axillary artery cannulation reduces the 
incidence of PND. This is supported by the important analysis by Svensson and colleagues 
who reviewed their stroke rates in 1336 circulatory arrest cases with different sites for 
arterial cannulation (ascending aorta, femoral, axillary, and innominate). They determined 
that cannulating a graft sewn to the right axillary artery resulted in the lowest incidence of 
PND (14). Although the mechanism of the protective effect of axillary cannulation is 
unknown, we have two hypotheses. The first is that axillary artery cannulation provides 
retrograde blood flow down the innominate artery, which may prevent atheroembolic 
disease from the ascending aorta. The second hypothesis relates to the differences in 
technique between uSACP and bSACP. In bSACP, there is a risk of cannulation-induced 
embolic injury from the introduction of cerebral perfusion catheters into the innominate and 
left common carotid arteries, especially in patients with atheromatous aortic arch disease. 
With uSACP, the innominate artery is occluded at the time of circulatory arrest and 
antegrade blood at 16°C is perfused at 10ml/kg/min through the right common carotid 
artery, right vertebral artery as well as through the left carotid system via intracranial and 
extracranial collaterals (58). This avoids manipulation of the ostia of the great vessels which 
are often covered with large, friable atherosclerotic plaques.  
In our initial report using this technique, we reviewed 412 arch reconstruction cases (elective 
and emergent) performed under MHCA with uSACP at core temperature of 25.7°C at the 
initiation of circulatory arrest. Operative mortality was 7.0%, and the incidence of PND and 
TND were 3.6% and 5.1% respectively with no cases of paraplegia. There were four (1%) 
deaths due to mesenteric inschemia, and three of these four patients presented with an acute 
Type A aortic dissection with preoperative visceral malperfusion. There was a 4.6% 
incidence of renal failure requiring dialysis. In a multivariate analysis, moderate 
hypothermia was not found to be an independent risk factor for mortality, PND, TND or 
renal failure requiring dialysis (55). Since that initial report, our experience has grown and 
we have continued to perform arch reconstructions at more moderate levels of hypothermia. 
In our recent study, we compared the outcomes of 257 patients undergoing arch 
reconstruction at 24.3°C to 265 patients undergoing arch reconstruction using at 28.5 °C. 
Both groups had adjunctive uSACP. There was no difference in mortality, TND or renal 
failure requiring dialysis between the two groups. The Stroke rate, cardiopulmonary bypass, 
cross clamp, post op ventilator times and ICU and hospital lengths of stay were all reduced 
in the 28.5˚C group (Table 2) (59). We feel that these results add to the growing body of 
literature which supports the strategy of moderate hypothermic circulatory arrest + uSACP 
as a highly effective cerebral protection strategy for aortic arch replacement (36, 54, 55, 56).  
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 Mild (>26°C) 
n=265 
Moderate (22-26°C) 
n=257 
P 
Temperature (°C) 28.5 ±1.1 24.3 ± 1.3 <0.01 
Mortality 5.8% 7.8% 0.37 
Stroke 1.5% 4.7% 0.04 
TND  3.9% 5.1% 0.49 
Dialysis  3.9% 3.9% 0.61 
CPB (min) 183 ± 57 209 ± 67 <0.01 
Cross Clamp (min) 145 ± 55 162 ± 65 <0.01 
HCA (min) 29 ± 14 34 ± 18 <0.01 
Ventilator time (hours) 44 ± 101 69 ± 128 0.02 
ICU Stay (hours) 102 ± 144 127 ± 149 0.06 
Hospital stay (Days) 9.5 ± 7.8 10.8 ± 7.2 0.06 
TND=Temporary Neurologic Dysfunction, HCA=Hypothermic Circulatory Arrest,*P<0.05 
Table 2. Comparative Analysis of Perioperative Data and Outcomes between Patients 
undergoing Aortic Arch Reconstruction at Mild vs. Moderate levels of Hypothermia. 
From Leshnower BG, Thourani VH, Myung RJ, et al. Aortic Arch Reconstruction at 28°C: A 
Comparative Analysis of Outcomes using Mild vs Moderate Hypothermia. Ann Thorac Surg 
Submitted. 
4. Conclusion 
Overall outcomes of patients undergoing aortic arch surgery have significantly improved 
over the past 3 decades. Advancements in surgical technique, prosthetic grafts and most 
importantly cerebral protection strategies have all contributed to better results. Despite the 
evidence presented in the preceding paragraphs, the optimal method of cerebral protection 
for arch reconstruction remains a controversial topic. All of these data are observational or 
retrospective studies. Due to surgeon bias and the limited number of arch cases performed, 
it is unlikely that there will ever be a prospective, randomized, controlled trial to determine 
the “gold standard” method of cerebral protection.  
As we have demonstrated, there are many different methods of cerebral protection which 
range from simple to complex. The arterial cannulation site, level of hypothermia, and the 
use of adjunctive cerebral perfusion are factors which have been shown to impact 
neurologic outcomes following arch reconstruction. It is highly likely that most 
cardiothoracic surgeons do 1-2 arch reconstructions/year (usually in the setting of Type A 
dissection) and are most comfortable using DHCA at 18˚C with femoral cannulation as their 
sole method of cerebral protection (Personal communications). The cerebral protection 
conferred by deep hypothermia is undisputed, and for short circulatory arrest times (<30 
minutes) the addition of RCP or ACP may not significantly impact neurologic outcomes. 
However it is generally agreed upon that for prolonged circulatory arrest times (>45) 
minutes, adjunctive ACP or RCP should be utilized. When using MHCA, ACP must be 
employed as it is the only adjunctive method reported with more moderate levels of 
hypothermia. Animal studies have demonstrated equivalent bilateral perfusion with the use 
of uSACP or bSACP, and clinical data has reported excellent neurologic outcomes with 
either method (43, 54, 55, 57).  Surgeons should be familiar with the technical aspects of all 
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of these different methods of cerebral protection. The arch pathology of each individual 
patient is different and may dictate the optimal method of cerebral protection on an 
individual case basis.  
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